http://rdf.ncbi.nlm.nih.gov/pubchem/patent/NO-20050572-L
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_6572ff5df928fd17340eb2a8cb6d8502 |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D491-14 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D491-147 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-4985 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D491-22 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D491-147 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D491-14 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-4375 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07B61-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-00 |
| filingDate | 2005-02-02-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_9b5294e2bb3874997343ac1d1397f7cc http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_d62317382cbd3c03a124be6d51bd5c79 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_658b2627a3b552d6889b7cf5bfbcc622 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_94f3019bde53714dee2d6f945df545e9 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_a0091c401b5a5fe68574594d9483321c http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_66c8a2986ce4f83135833b5459084446 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_94edfb8cf668db57831d66f905c467b1 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_dde468f2eb7ef438e544637c296cfe0e |
| publicationDate | 2005-08-04-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | NO-20050572-L |
| titleOfInvention | Novel benzo [b] chromo-naphthyridin-7-one and pyrano [2 ', 3': 7,8] quino [2,3-b] quinoxaline-7-one compounds, processes for their preparation and pharmaceutical compositions containing them |
| abstract | Compounds of formula (I) their isomers defined in the specification, N-oxides, and also addition salts thereof with a pharmaceutically acceptable acid or base. drugs. Compounds of formula (I): 0) wherein: ¿B B, B, represents a carbon or nitrogen atom, ¿X, Y, Xi and Yl represent a group selected from hydrogen, halogen, hydroxy, alkoxy, nitro, cyano, trihaloalkyl and I9K, Sb wherein R, and R4 are as defined in the specification, ¿R4 represents a hydrogen atom or an alkyl group, ¿R, represents a group selected from hydrogen, alkyl, -OR '., -NR'.R't , -OT.-OR "., -NR -.- T.-lIR-.R '^, 11R" .- C (O) -T, H, -0-C (0) -TH, -0- T.-lIR.'Rj ', -NR ", - T, -OR"., -LJR ", - T.-æjR". And -NR ", - C {O) -T.-NR'.R wherein R ', R \, R ", and T. are as defined in the specification, ¿R3, R ^ represents a hydrogen atom or an alkyl group, ¿A represents a group of formula -C31 (R5) -CH (R ,) -, -CH = C (R,) -, -C (R,) = CH-, -C (O) -CH (R,) - or -CH (R,) - C (O) - wherein R 5, R 1, R, and R, are as defined in the specification, their isomers defined in the specification, N-oxides, and also the addition salts thereof with a pharmaceutically acceptable acid or base. |
| priorityDate | 2004-02-03-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 33.